Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 21 April 1989:
Vol. 244. no. 4902, pp. 362 - 364
DOI: 10.1126/science.2496467

Articles

Science, Vol 244, Issue 4902, 362-364
Copyright © 1989 by American Association for the Advancement of Science


articles

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

G Kuo, QL Choo, HJ Alter, GL Gitnick, AG Redeker, RH Purcell, T Miyamura, JL Dienstag, MJ Alter, CE Stevens, and al. et

Chiron Corporation, Emeryville, CA 94608.

A specific assay has been developed for a blood-borne non-A, non-B hepatitis (NANBH) virus in which a polypeptide synthesized in recombinant yeast clones of the hepatitis C virus (HCV) is used to capture circulating viral antibodies. HCV antibodies were detected in six of seven human sera that were shown previously to transmit NANBH to chimpanzees. Assays of ten blood transfusions in the United States that resulted in chronic NANBH revealed that there was at least one positive blood donor in nine of these cases and that all ten recipients seroconverted during their illnesses. About 80 percent of chronic, post-transfusion NANBH (PT-NANBH) patients from Italy and Japan had circulating HCV antibody; a much lower frequency (15 percent) was observed in acute, resolving infections. In addition, 58 percent of NANBH patients from the United States with no identifiable source of parenteral exposure to the virus were also positive for HCV antibody. These data indicate that HCV is a major cause of NANBH throughout the world.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells.
Y. Bungyoku, I. Shoji, T. Makine, T. Adachi, K. Hayashida, M. Nagano-Fujii, Y.-H. Ide, L. Deng, and H. Hotta (2009)
J. Gen. Virol. 90, 1681-1691
   Abstract »    Full Text »    PDF »
In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor.
T.-I Lin, O. Lenz, G. Fanning, T. Verbinnen, F. Delouvroy, A. Scholliers, K. Vermeiren, A. Rosenquist, M. Edlund, B. Samuelsson, et al. (2009)
Antimicrob. Agents Chemother. 53, 1377-1385
   Abstract »    Full Text »    PDF »
Clinical Performance Evaluation of Four Automated Chemiluminescence Immunoassays for Hepatitis C Virus Antibody Detection.
S. Kim, J.-H. Kim, S. Yoon, Y.-H. Park, and H.-S. Kim (2008)
J. Clin. Microbiol. 46, 3919-3923
   Abstract »    Full Text »    PDF »
The History of Tumor Virology.
R. T. Javier and J. S. Butel (2008)
Cancer Res. 68, 7693-7706
   Abstract »    Full Text »    PDF »
Induction of Broad CD4+ and CD8+ T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5 .
Y. Lin, T. Kwon, J. Polo, Y.-F. Zhu, S. Coates, K. Crawford, C. Dong, M. Wininger, J. Hall, M. Selby, et al. (2008)
J. Virol. 82, 7492-7503
   Abstract »    Full Text »    PDF »
Hepatitis C in Schizophrenia: Screening Experience in a Community-Dwelling Clozapine Cohort.
O. Freudenreich, R. T. Gandhi, J. P. Walsh, D. C. Henderson, and D. C. Goff (2007)
Psychosomatics 48, 405-411
   Abstract »    Full Text »    PDF »
Involvement of the PA28{gamma}-Dependent Pathway in Insulin Resistance Induced by Hepatitis C Virus Core Protein.
H. Miyamoto, K. Moriishi, K. Moriya, S. Murata, K. Tanaka, T. Suzuki, T. Miyamura, K. Koike, and Y. Matsuura (2007)
J. Virol. 81, 1727-1735
   Abstract »    Full Text »    PDF »
E6AP Ubiquitin Ligase Mediates Ubiquitylation and Degradation of Hepatitis C Virus Core Protein.
M. Shirakura, K. Murakami, T. Ichimura, R. Suzuki, T. Shimoji, K. Fukuda, K. Abe, S. Sato, M. Fukasawa, Y. Yamakawa, et al. (2007)
J. Virol. 81, 1174-1185
   Abstract »    Full Text »    PDF »
High-affinity aptamers to subtype 3a hepatitis C virus polymerase display genotypic specificity..
L. A. Jones, L. E. Clancy, W. D. Rawlinson, and P. A. White (2006)
Antimicrob. Agents Chemother. 50, 3019-3027
   Abstract »    Full Text »    PDF »
Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein..
S. Sato, M. Fukasawa, Y. Yamakawa, T. Natsume, T. Suzuki, I. Shoji, H. Aizaki, T. Miyamura, and M. Nishijima (2006)
J. Biochem. 139, 921-930
   Abstract »    Full Text »    PDF »
E2 of Hepatitis C Virus Inhibits Apoptosis.
S. H. Lee, Y. K. Kim, C. S. Kim, S. K. Seol, J. Kim, S. Cho, Y. L. Song, R. Bartenschlager, and S. K. Jang (2005)
J. Immunol. 175, 8226-8235
   Abstract »    Full Text »    PDF »
Interferon resistance of hepatitis C virus replicon-harbouring cells is caused by functional disruption of type I interferon receptors.
K. Naka, K. Takemoto, K.-i. Abe, H. Dansako, M. Ikeda, K. Shimotohno, and N. Kato (2005)
J. Gen. Virol. 86, 2787-2792
   Abstract »    Full Text »    PDF »
Hepatitis C Virus NS2/3 Processing Is Required for NS3 Stability and Viral RNA Replication.
S. Welbourn, R. Green, I. Gamache, S. Dandache, V. Lohmann, R. Bartenschlager, K. Meerovitch, and A. Pause (2005)
J. Biol. Chem. 280, 29604-29611
   Abstract »    Full Text »    PDF »
Simultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV Infection.
S. Laperche, N. Le Marrec, A. Girault, F. Bouchardeau, A. Servant-Delmas, M. Maniez-Montreuil, P. Gallian, T. Levayer, P. Morel, and N. Simon (2005)
J. Clin. Microbiol. 43, 3877-3883
   Abstract »    Full Text »    PDF »
Design of Novel Conformational and Genotype-Specific Antigens for Improving Sensitivity of Immunoassays for Hepatitis C Virus-Specific Antibodies.
S. Lin, P. Arcangel, A. Medina-Selby, D. Coit, P. Ng, S. Nguyen, C. McCoin, A. Gyenes, C. Hu, L. Tandeske, et al. (2005)
J. Clin. Microbiol. 43, 3917-3924
   Abstract »    Full Text »    PDF »
Genetic variation and dynamics of hepatitis C virus replicons in long-term cell culture.
N. Kato, T. Nakamura, H. Dansako, K. Namba, K.-i. Abe, A. Nozaki, K. Naka, M. Ikeda, and K. Shimotohno (2005)
J. Gen. Virol. 86, 645-656
   Abstract »    Full Text »    PDF »
Nonhepatic Cell Lines HeLa and 293 Support Efficient Replication of the Hepatitis C Virus Genotype 2a Subgenomic Replicon.
T. Kato, T. Date, M. Miyamoto, Z. Zhao, M. Mizokami, and T. Wakita (2005)
J. Virol. 79, 592-596
   Abstract »    Full Text »    PDF »
Genetic diversity and evolution of hepatitis C virus - 15 years on.
P. Simmonds (2004)
J. Gen. Virol. 85, 3173-3188
   Abstract »    Full Text »    PDF »
Intramembrane Proteolysis and Endoplasmic Reticulum Retention of Hepatitis C Virus Core Protein.
K. Okamoto, K. Moriishi, T. Miyamura, and Y. Matsuura (2004)
J. Virol. 78, 6370-6380
   Abstract »    Full Text »    PDF »
Steatosis and intrahepatic lymphocyte recruitment in hepatitis C virus transgenic mice.
T. Alonzi, C. Agrati, B. Costabile, C. Cicchini, L. Amicone, C. Cavallari, C. D. Rocca, A. Folgori, C. Fipaldini, F. Poccia, et al. (2004)
J. Gen. Virol. 85, 1509-1520
   Abstract »    Full Text »    PDF »
Genotype 2a Hepatitis C Virus Subgenomic Replicon Can Replicate in HepG2 and IMY-N9 Cells.
T. Date, T. Kato, M. Miyamoto, Z. Zhao, K. Yasui, M. Mizokami, and T. Wakita (2004)
J. Biol. Chem. 279, 22371-22376
   Abstract »    Full Text »    PDF »
Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C.
H Yoshida, R Tateishi, Y Arakawa, M Sata, S Fujiyama, S Nishiguchi, H Ishibashi, G Yamada, O Yokosuka, Y Shiratori, et al. (2004)
Gut 53, 425-430
   Abstract »    Full Text »    PDF »
Evaluation of Common Liver Problems.
A. L. Adrain, H. Ramberan, and G. J. Weaver (2004)
J Am Podiatr Med Assoc 94, 149-156
   Abstract »    Full Text »    PDF »
Promotion of Microsatellite Instability by Hepatitis C Virus Core Protein in Human Non-neoplastic Hepatocyte Cells.
A. Naganuma, H. Dansako, T. Nakamura, A. Nozaki, and N. Kato (2004)
Cancer Res. 64, 1307-1314
   Abstract »    Full Text »    PDF »
Laboratory Evaluation of a Fully Automated Chemiluminescence Immunoassay for Rapid Detection of HBsAg, Antibodies to HBsAg, and Antibodies to Hepatitis C Virus.
N. Ismail, G. E. Fish, and M. B. Smith (2004)
J. Clin. Microbiol. 42, 610-617
   Abstract »    Full Text »    PDF »
Expression and Purification of a Hepatitis C Virus NS3/4A Complex, and Characterization of Its Helicase Activity with the Scintillation Proximity Assay System.
K. Kyono, M. Miyashiro, and I. Taguchi (2004)
J. Biochem. 135, 245-252
   Abstract »    Full Text »    PDF »
Evolutionary study of HVR1 of E2 in chronic hepatitis C virus infection.
V. Alfonso, D. M. Flichman, S. Sookoian, V. A. Mbayed, and R. H. Campos (2004)
J. Gen. Virol. 85, 39-46
   Abstract »    Full Text »    PDF »
Proteasome Activator PA28{gamma}-Dependent Nuclear Retention and Degradation of Hepatitis C Virus Core Protein.
K. Moriishi, T. Okabayashi, K. Nakai, K. Moriya, K. Koike, S. Murata, T. Chiba, K. Tanaka, R. Suzuki, T. Suzuki, et al. (2003)
J. Virol. 77, 10237-10249
   Abstract »    Full Text »    PDF »
Characterization of ATPase Activity of a Hepatitis C Virus NS3 Helicase Domain, and Analysis Involving Mercuric Reagents.
K. Kyono, M. Miyashiro, and I. Taguchi (2003)
J. Biochem. 134, 505-511
   Abstract »    Full Text »    PDF »
Morphine Enhances Hepatitis C Virus (HCV) Replicon Expression.
Y. Li, T. Zhang, S. D. Douglas, J.-P. Lai, W.-D. Xiao, D. E. Pleasure, and W.-Z. Ho (2003)
Am. J. Pathol. 163, 1167-1175
   Abstract »    Full Text »    PDF »
Hepatitis C Virus NS5A Protein Modulates c-Jun N-terminal Kinase through Interaction with Tumor Necrosis Factor Receptor-associated Factor 2.
K.-J. Park, S.-H. Choi, D.-H. Choi, J.-M. Park, S. W. Yie, S. Y. Lee, and S. B. Hwang (2003)
J. Biol. Chem. 278, 30711-30718
   Abstract »    Full Text »    PDF »
Managing Occupational Risks for Hepatitis C Transmission in the Health Care Setting.
D. K. Henderson (2003)
Clin. Microbiol. Rev. 16, 546-568
   Abstract »    Full Text »    PDF »
An NS3 Serine Protease Inhibitor Abrogates Replication of Subgenomic Hepatitis C Virus RNA.
A. Pause, G. Kukolj, M. Bailey, M. Brault, F. Do, T. Halmos, L. Lagace, R. Maurice, M. Marquis, G. McKercher, et al. (2003)
J. Biol. Chem. 278, 20374-20380
   Abstract »    Full Text »    PDF »
Inhibition of Hepatitis C Virus RNA Replication by 2'-Modified Nucleoside Analogs.
S. S. Carroll, J. E. Tomassini, M. Bosserman, K. Getty, M. W. Stahlhut, A. B. Eldrup, B. Bhat, D. Hall, A. L. Simcoe, R. LaFemina, et al. (2003)
J. Biol. Chem. 278, 11979-11984
   Abstract »    Full Text »    PDF »
Identification of a Lactoferrin-derived Peptide Possessing Binding Activity to Hepatitis C Virus E2 Envelope Protein.
A. Nozaki, M. Ikeda, A. Naganuma, T. Nakamura, M. Inudoh, K. Tanaka, and N. Kato (2003)
J. Biol. Chem. 278, 10162-10173
   Abstract »    Full Text »    PDF »
Laboratory Assays for Diagnosis and Management of Hepatitis C Virus Infection.
S. S. Richter (2002)
J. Clin. Microbiol. 40, 4407-4412
   Full Text »    PDF »
Quantification of Hepatitis C Virus in Human Liver and Serum Samples by Using LightCycler Reverse Transcriptase PCR.
P. A. White, Y. Pan, A. J. Freeman, G. Marinos, R. A. Ffrench, A. R. Lloyd, and W. D. Rawlinson (2002)
J. Clin. Microbiol. 40, 4346-4348
   Abstract »    Full Text »    PDF »
Diverging Effects of Human Recombinant Anti-Hepatitis C Virus (HCV) Antibody Fragments Derived from a Single Patient on the Infectivity of a Vesicular Stomatitis Virus/HCV Pseudotype.
R. Burioni, Y. Matsuura, N. Mancini, H. Tani, T. Miyamura, P. E. Varaldo, and M. Clementi (2002)
J. Virol. 76, 11775-11779
   Abstract »    Full Text »    PDF »
Highly Sensitive Multiplex Assay for Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNA.
C. Giachetti, J. M. Linnen, D. P. Kolk, J. Dockter, K. Gillotte-Taylor, M. Park, M. Ho-Sing-Loy, M. K. McCormick, L. T. Mimms, and S. H. McDonough (2002)
J. Clin. Microbiol. 40, 2408-2419
   Abstract »    Full Text »    PDF »
Expression of Hepatitis C Virus Proteins Induces Distinct Membrane Alterations Including a Candidate Viral Replication Complex.
D. Egger, B. Wolk, R. Gosert, L. Bianchi, H. E. Blum, D. Moradpour, and K. Bienz (2002)
J. Virol. 76, 5974-5984
   Abstract »    Full Text »    PDF »
Comparison of Second- and Third-Generation Enzyme Immunoassays for Detecting Antibodies to Hepatitis C Virus.
M. Abdel-Hamid, M. El-Daly, S. El-Kafrawy, N. Mikhail, G. T. Strickland, and A. D. Fix (2002)
J. Clin. Microbiol. 40, 1656-1659
   Abstract »    Full Text »    PDF »
Nonstructural 5A Protein of Hepatitis C Virus Modulates Tumor Necrosis Factor alpha -stimulated Nuclear Factor kappa B Activation.
K.-J. Park, S.-H. Choi, S. Y. Lee, S. B. Hwang, and M. M. C. Lai (2002)
J. Biol. Chem. 277, 13122-13128
   Abstract »    Full Text »    PDF »
Use of Polymerase Chain Reaction for Early Detection and Management of Hepatitis C Virus Infection after Needlestick Injury.
T. Y. Wang, H. T. Kuo, L. C. Chen, Y. T. Chen, C. N. Lin, and M. M. Lee (2002)
Ann. Clin. Lab. Sci. 32, 137-141
   Abstract »    Full Text »    PDF »
Hepatitis C Virus (HCV) NS5A Binds RNA-dependent RNA Polymerase (RdRP) NS5B and Modulates RNA-dependent RNA Polymerase Activity.
Y. Shirota, H. Luo, W. Qin, S. Kaneko, T. Yamashita, K. Kobayashi, and S. Murakami (2002)
J. Biol. Chem. 277, 11149-11155
   Abstract »    Full Text »    PDF »
Persistent and Transient Replication of Full-Length Hepatitis C Virus Genomes in Cell Culture.
T. Pietschmann, V. Lohmann, A. Kaul, N. Krieger, G. Rinck, G. Rutter, D. Strand, and R. Bartenschlager (2002)
J. Virol. 76, 4008-4021
   Abstract »    Full Text »    PDF »
Analysis of the C-Terminal Membrane Anchor Domains of Hepatitis C Virus Glycoproteins E1 and E2: toward a Topological Model.
B. Charloteaux, L. Lins, H. Moereels, and R. Brasseur (2002)
J. Virol. 76, 1944-1958
   Abstract »    Full Text »    PDF »
In Vitro Characterization of a Purified NS2/3 Protease Variant of Hepatitis C Virus.
D. Thibeault, R. Maurice, L. Pilote, D. Lamarre, and A. Pause (2001)
J. Biol. Chem. 276, 46678-46684
   Abstract »    Full Text »    PDF »
Mapping B-Cell Epitopes of Hepatitis C Virus E2 Glycoprotein Using Human Monoclonal Antibodies from Phage Display Libraries.
F. Bugli, N. Mancini, C.-Y. Kang, C. Di Campli, A. Grieco, A. Manzin, A. Gabrielli, A. Gasbarrini, G. Fadda, P. E. Varaldo, et al. (2001)
J. Virol. 75, 9986-9990
   Abstract »    Full Text »    PDF »
The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines.
S. Hamaia, C. Li, and J.-P. Allain (2001)
Blood 98, 2293-2300
   Abstract »    Full Text »    PDF »
Novel Approach To Reduce the Hepatitis C Virus (HCV) Window Period: Clinical Evaluation of a New Enzyme-Linked Immunosorbent Assay for HCV Core Antigen.
G. Icardi, F. Ansaldi, B. M. Bruzzone, P. Durando, S. Lee, C. de Luigi, and P. Crovari (2001)
J. Clin. Microbiol. 39, 3110-3114
   Abstract »    Full Text »    PDF »
Structure-Based Mutational Analysis of the Hepatitis C Virus NS3 Helicase.
C.-L. Tai, W.-C. Pan, S.-H. Liaw, U.-C. Yang, L.-H. Hwang, and D.-S. Chen (2001)
J. Virol. 75, 8289-8297
   Abstract »    Full Text »    PDF »
Design, high-level expression, purification and characterization of soluble fragments of the hepatitis C virus NS3 RNA helicase suitable for NMR-based drug discovery methods and mechanistic studies.
J. J. Gesell, D. Liu, V. S. Madison, T. Hesson, Y.-S. Wang, P. C. Weber, and D. F. Wyss (2001)
Protein Eng. Des. Sel. 14, 573-582
   Abstract »    Full Text »    PDF »
Clinical guidelines on the management of hepatitis C.
J C L Booth, J O'Grady, and J Neuberger (2001)
Gut 49, I1-21
   Full Text »    PDF »
Detection of Diverse Hepatitis C Virus (HCV)-Specific Cytotoxic T Lymphocytes in Peripheral Blood of Infected Persons by Screening for Responses to All Translated Proteins of HCV.
D. K. H. Wong, D. D. Dudley, P. B. Dohrenwend, G. M. Lauer, R. T. Chung, D. L. Thomas, and B. D. Walker (2001)
J. Virol. 75, 1229-1235
   Abstract »    Full Text »
In Situ Detection of Hepatitis C Virus RNA in Salivary Glands.
J. J. Arrieta, E. Rodriguez-Inigo, N. Ortiz-Movilla, J. Bartolome, M. Pardo, F. Manzarbeitia, H. Oliva, D. M. Macias, and V. Carreno (2001)
Am. J. Pathol. 158, 259-264
   Abstract »    Full Text »    PDF »
Depression in Korean Immigrants With Hepatitis B and Related Liver Diseases.
E. J.S. Kunkel, J. S. Kim, H.-W. Hann, O. Oyesanmi, L. A. Menefee, H. L. Field, P. L. Lartey, and R. E. Myers (2000)
Psychosomatics 41, 472-480
   Abstract »    Full Text »
Roles of the AX4GKS and Arginine-Rich Motifs of Hepatitis C Virus RNA Helicase in ATP- and Viral RNA-Binding Activity.
S. C. Chang, J.-C. Cheng, Y.-H. Kou, C.-H. Kao, C.-H. Chiu, H.-Y. Wu, and M.-F. Chang (2000)
J. Virol. 74, 9732-9737
   Abstract »    Full Text »
Prognosis of Anti-Hepatitis C Virus Antibody-Positive Patients on Regular Hemodialysis Therapy.
E. NAKAYAMA, T. AKIBA, F. MARUMO, and C. SATO (2000)
J. Am. Soc. Nephrol. 11, 1896-1902
   Abstract »    Full Text »
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients.
B. L. KASISKE, M. A. VAZQUEZ, W. E. HARMON, R. S. BROWN, G. M. DANOVITCH, R. S. GASTON, D. ROTH, J. D. SCANDLING JR., and G. G. SINGER (2000)
J. Am. Soc. Nephrol. 11 , S1-S86
   Abstract »    Full Text »    PDF »
Activation of the Interferon-Inducible 2'-5'-Oligoadenylate Synthetase Gene by Hepatitis C Virus Core Protein.
A. Naganuma, A. Nozaki, T. Tanaka, K. Sugiyama, H. Takagi, M. Mori, K. Shimotohno, and N. Kato (2000)
J. Virol. 74, 8744-8750
   Abstract »    Full Text »
Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein.
R. G. Hope and J. McLauchlan (2000)
J. Gen. Virol. 81, 1913-1925
   Abstract »    Full Text »
Prevalence of hepatitis C among pregnant women attending an inner London obstetric department: uptake and acceptability of named antenatal testing.
C Ward, G Tudor-Williams, T Cotzias, S Hargreaves, L Regan, and G R Foster (2000)
Gut 47, 277-280
   Abstract »    Full Text »    PDF »
Transfusion Medicine: An Overview and Update.
P. M. Ness (2000)
Clin. Chem. 46, 1270-1276
   Abstract »    Full Text »    PDF »
Development of a High Throughput Scintillation Proximity Assay for Hepatitis C Virus NS3 Protease That Reduces the Proportion of Competitive Inhibitors Identified.
A. Fowler, M. Price-Jones, K. Hughes, J. Anson, R. Lingham, and M. Schulman (2000)
J Biomol Screen 5, 153-158
   Abstract »    PDF »
Cell Fusion Activity of Hepatitis C Virus Envelope Proteins.
S. Takikawa, K. Ishii, H. Aizaki, T. Suzuki, H. Asakura, Y. Matsuura, and T. Miyamura (2000)
J. Virol. 74, 5066-5074
   Abstract »    Full Text »
Nonstructural Protein 5A of Hepatitis C Virus Inhibits the Function of Karyopherin beta 3.
K. M. Chung, J. Lee, J.-E. Kim, O.-K. Song, S. Cho, J. Lim, M. Seedorf, B. Hahm, and S. K. Jang (2000)
J. Virol. 74, 5233-5241
   Abstract »    Full Text »
EFFECT OF ALCOHOL CONSUMPTION ON THE PROGRESSION OF HEPATITIS C VIRUS INFECTION AND RISK OF HEPATOCELLULAR CARCINOMA IN JAPANESE PATIENTS.
K. N. KHAN and H. YATSUHASHI (2000)
Alcohol Alcohol. 35, 286-295
   Abstract »    Full Text »    PDF »
Clinical Significance of Hepatitis C Virus Genotypes.
N. N. Zein (2000)
Clin. Microbiol. Rev. 13, 223-235
   Abstract »    Full Text »    PDF »
Enhancement of Immunoglobulin G2a and Cytotoxic T-Lymphocyte Responses by a Booster Immunization with Recombinant Hepatitis C Virus E2 Protein in E2 DNA-Primed Mice.
M. K. Song, S. W. Lee, Y. S. Suh, K. J. Lee, and Y. C. Sung (2000)
J. Virol. 74, 2920-2925
   Abstract »    Full Text »
Biochemical characterization of a hepatitis C virus RNA-dependent RNA polymerase mutant lacking the C-terminal hydrophobic sequence.
L. Tomei, R. L. Vitale, I. Incitti, S. Serafini, S. Altamura, A. Vitelli, and R. De Francesco (2000)
J. Gen. Virol. 81, 759-767
   Abstract »    Full Text »
Subcellular Localization, Stability, and trans-Cleavage Competence of the Hepatitis C Virus NS3-NS4A Complex Expressed in Tetracycline-Regulated Cell Lines.
B. Wölk, D. Sansonno, H.-G. Kräusslich, F. Dammacco, C. M. Rice, H. E. Blum, and D. Moradpour (2000)
J. Virol. 74, 2293-2304
   Abstract »    Full Text »
De Novo Initiation of RNA Synthesis by Hepatitis C Virus Nonstructural Protein 5B Polymerase.
W. Zhong, A. S. Uss, E. Ferrari, J. Y. N. Lau, and Z. Hong (2000)
J. Virol. 74, 2017-2022
   Abstract »    Full Text »
Simplified Hepatitis C Virus Genotyping by Heteroduplex Mobility Analysis.
P. A. White, X. Zhai, I. Carter, Y. Zhao, and W. D. Rawlinson (2000)
J. Clin. Microbiol. 38, 477-482
   Abstract »    Full Text »
Clinical and Histologic Features of Chronic Hepatitis C Virus Infection After Blood Transfusion in Japanese Children.
A. Hoshiyama, A. Kimura, T. Fujisawa, M. Kage, and H. Kato (2000)
Pediatrics 105, 62-65
   Abstract »    Full Text »    PDF »
Inhibition of Hepatitis C Virus NS2/3 Processing by NS4A Peptides. IMPLICATIONS FOR CONTROL OF VIRAL PROCESSING.
P. L. Darke, A. R. Jacobs, L. Waxman, and L. C. Kuo (1999)
J. Biol. Chem. 274, 34511-34514
   Abstract »    Full Text »    PDF »
Interaction of Hepatitis C Virus Core Protein with Viral Sense RNA and Suppression of Its Translation.
T. Shimoike, S. Mimori, H. Tani, Y. Matsuura, and T. Miyamura (1999)
J. Virol. 73, 9718-9725
   Abstract »    Full Text »
Expression of Hepatitis C Virus Proteins Inhibits Signal Transduction through the Jak-STAT Pathway.
M. H. Heim, D. Moradpour, and H. E. Blum (1999)
J. Virol. 73, 8469-8475
   Abstract »    Full Text »    PDF »
Structure-Based Mutagenesis Study of Hepatitis C Virus NS3 Helicase.
C. Lin and J. L. Kim (1999)
J. Virol. 73, 8798-8807
   Abstract »    Full Text »    PDF »
Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus.
C M Chu, C T Yeh, and Y F Liaw (1999)
Gut 45, 613-617
   Abstract »    Full Text »    PDF »
Expression of Noncovalent Hepatitis C Virus Envelope E1-E2 Complexes Is Not Required for the Induction of Antibodies with Neutralizing Properties following DNA Immunization.
A. Fournillier, E. Depla, P. Karayiannis, O. Vidalin, G. Maertens, C. Trépo, and G. Inchauspé (1999)
J. Virol. 73, 7497-7504
   Abstract »    Full Text »
Lack of evidence for the heterosexual transmission of hepatitis C.
G. Neumayr, A. Propst, H. Schwaighofer, G. Judmaier, and W. Vogel (1999)
QJM 92, 505-508
   Abstract »    Full Text »    PDF »
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994.
M. J. Alter, D. Kruszon-Moran, O. V. Nainan, G. M. McQuillan, F. Gao, L. A. Moyer, R. A. Kaslow, and H. S. Margolis (1999)
N. Engl. J. Med. 341, 556-562
   Abstract »    Full Text »    PDF »
Anti-HCV seropositivity among haemodialysis patients of Iranian origin.
G. Rais-Jalali and P. Khajehdehi (1999)
Nephrol. Dial. Transplant. 14, 2055-2056
   Full Text »    PDF »
High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan.
H Marusawa, Y Osaki, T Kimura, K Ito, Y Yamashita, T Eguchi, M Kudo, Y Yamamoto, H Kojima, H Seno, et al. (1999)
Gut 45, 284-288
   Abstract »    Full Text »    PDF »
Development of a Simple and Highly Sensitive Enzyme Immunoassay for Hepatitis C Virus Core Antigen.
K. Aoyagi, C. Ohue, K. Iida, T. Kimura, E. Tanaka, K. Kiyosawa, and S. Yagi (1999)
J. Clin. Microbiol. 37, 1802-1808
   Abstract »    Full Text »
Hepatitis C Virus Core Protein Inhibits Fas- and Tumor Necrosis Factor Alpha-Mediated Apoptosis via NF-kappa B Activation.
H. Marusawa, M. Hijikata, T. Chiba, and K. Shimotohno (1999)
J. Virol. 73, 4713-4720
   Abstract »    Full Text »
Hepatitis C Virus Core Protein Binds to a DEAD Box RNA Helicase.
N. Mamiya and H. J. Worman (1999)
J. Biol. Chem. 274, 15751-15756
   Abstract »    Full Text »    PDF »
Use of a Novel Hepatitis C Virus (HCV) Major-Epitope Chimeric Polypeptide for Diagnosis of HCV Infection.
D. Y. Chien, P. Arcangel, A. Medina-Selby, D. Coit, M. Baumeister, S. Nguyen, C. George-Nascimento, A. Gyenes, G. Kuo, and P. Valenzuela (1999)
J. Clin. Microbiol. 37, 1393-1397
   Abstract »    Full Text »
Hepatitis C Virus Core Protein Interacts with Cellular Putative RNA Helicase.
L.-R. You, C.-M. Chen, T.-S. Yeh, T.-Y. Tsai, R.-T. Mai, C.-H. Lin, and Y.-H. W. Lee (1999)
J. Virol. 73, 2841-2853
   Abstract »    Full Text »
Hepatitis C virus recurrence after liver transplantation.
T BIZOLLON, C DUCERF, C TREPO, and D MUTIMER (1999)
Gut 44, 575-578
   Abstract »    Full Text »    PDF »
High-Throughput Real-Time Reverse Transcription-PCR Quantitation of Hepatitis C Virus RNA.
M. Martell, J. Gómez, J. I. Esteban, S. Sauleda, J. Quer, B. Cabot, R. Esteban, and J. Guardia (1999)
J. Clin. Microbiol. 37, 327-332
   Abstract »    Full Text »
Poliovirus/Hepatitis C Virus (Internal Ribosomal Entry Site-Core) Chimeric Viruses: Improved Growth Properties through Modification of a Proteolytic Cleavage Site and Requirement for Core RNA Sequences but Not for Core-Related Polypeptides.
W. D. Zhao, E. Wimmer, and F. C. Lahser (1999)
J. Virol. 73, 1546-1554
   Abstract »    Full Text »
Hepatitis C Virus Core Protein Enhances NF-kappa B Signal Pathway Triggering by Lymphotoxin-beta Receptor Ligand and Tumor Necrosis Factor Alpha.
L.-R. You, C.-M. Chen, and Y.-H. W. Lee (1999)
J. Virol. 73, 1672-1681
   Abstract »    Full Text »
Genetic and Serological Evidence for Multiple Instances of Unrecognized Transmission of Hepatitis C Virus in Hemodialysis Units.
M. Mizuno, T. Higuchi, K. Kanmatsuse, and M. Esumi (1998)
J. Clin. Microbiol. 36, 2926-2931
   Abstract »    Full Text »
Confirmation of Nosocomial Transmission of Hepatitis C Virus by Phylogenetic Analysis of the NS5-B Region.
H. Norder, A. Bergström, I. Uhnoo, J. Aldén, L. Weiss, J. Czajkowski, and L. Magnius (1998)
J. Clin. Microbiol. 36, 3066-3069
   Abstract »    Full Text »
Optimal Induction of Hepatitis C Virus Envelope-Specific Immunity by Bicistronic Plasmid DNA Inoculation with the Granulocyte-Macrophage Colony-Stimulating Factor Gene.
S. W. Lee, J. H. Cho, and Y. C. Sung (1998)
J. Virol. 72, 8430-8436
   Abstract »    Full Text »    PDF »
The Metal Binding Site of the Hepatitis C Virus NS3 Protease. A SPECTROSCOPIC INVESTIGATION.
A. Urbani, R. Bazzo, M. C. Nardi, D. O. Cicero, R. De Francesco, C. Steinkuhler, and G. Barbato (1998)
J. Biol. Chem. 273, 18760-18769
   Abstract »    Full Text »    PDF »
The Native Form and Maturation Process of Hepatitis C Virus Core Protein.
K. Yasui, T. Wakita, K. Tsukiyama-Kohara, S.-I. Funahashi, M. Ichikawa, T. Kajita, D. Moradpour, J. R. Wands, and M. Kohara (1998)
J. Virol. 72, 6048-6055
   Abstract »    Full Text »    PDF »
RNA-dependent RNA Polymerase Activity of the Soluble Recombinant Hepatitis C Virus NS5B Protein Truncated at the C-terminal Region.
T. Yamashita, S. Kaneko, Y. Shirota, W. Qin, T. Nomura, K. Kobayashi, and S. Murakami (1998)
J. Biol. Chem. 273, 15479-15486
   Abstract »    Full Text »    PDF »
Hepatitis C Virus Infections in Dialysis Centers in The Netherlands: a National Survey by Serological and Molecular Methods.
P. M. Schneeberger, I. Keur, W. van der Vliet, K. van Hoek, H. Boswijk, A. M. van Loon, W. C. van Dijk, R. H. Kauffmann, W. Quint, and L.-J. van Doorn (1998)
J. Clin. Microbiol. 36, 1711-1715
   Abstract »    Full Text »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)